Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDY…
Biotechnology
US, Cambridge [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Sarepta Therapeutics, Inc.'s gradings, price targets and earnings estimates. None
All monetary values are presented in USD ($). E stands for Estimate.
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | -3.3100 | -3.270 | 14 | 10 | -111 | -126 | -68 | -122 | -180 | -125 | 31 | 5 |
| 2015 | -3.3900 | -4.849 | 9 | 1 | -135 | -182 | -131 | -178 | -227 | -182 | 49 | 0.53 |
| 2016 | -5.2000 | -5.035 | 1 | 4 | -220 | -293 | -220 | -287 | -366 | -293 | 75 | 2 |
| 2017 | -5.4900 | -0.768 | 5 | 154 | -267 | -70 | -266 | -101 | -266 | -107 | 83 | 80 |
| 2018 | -0.8600 | -4.410 | 154 | 301 | -50 | -259 | -238 | -229 | -143 | -247 | 122 | 145 |
| 2019 | -5.4600 | -7.973 | 301 | 379 | -361 | -555 | -342 | -502 | -343 | -548 | 207 | 242 |
| 2020 | -9.7100 | -6.545 | 380 | 540 | -715 | -604 | -469 | -355 | -522 | -376 | 284 | 282 |
| 2021 | -7.1100 | -5.109 | 540 | 695 | -554 | -435 | -529 | -340 | -564 | -486 | 317 | 273 |
| 2022 | -5.1500 | -8.063 | 701 | 924 | -418 | -421 | -412 | -328 | -449 | -482 | 282 | 267 |
| 2023 | -8.0300 | -6.573 | 933 | 1,232 | -703 | 47 | -473 | -322 | -536 | -490 | 451 | 277 |
| 2024 | -5.8000 | 2.040 | 1,243 | 1,740 | -535 | 188 | -267 | -1,145 | -267 | -1,213 | 481 | 908 |
| 2025 | - | 11.222 | - | 3,099 | - | 1,067 | - | -2,039 | - | -2,160 | - | 1,618 |
| 2026 | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |